JYOTHYLAB Jyothy Labs Q4 FY26 results (Jan–Mar 2026) and concall
Jyothy Labs reported a mixed Q4 FY26, with strong volume growth in Fabric Care and Personal Care segments, and significant loss reduction in Household Insecticides. However, profitability was impacted by elevated input costs and intense competition, leading to a 400 bps decline in gross margin and 330 bps in EBITDA margin. The company remains debt-free with a healthy cash balance and is actively pursuing M&A opportunities while navigating an uncertain demand and cost environment.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 7.7%, net profit down 11.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 733 | 704 | 666 | 751 | 736 +0% | 740 +5% | 717 +8% |
| EBITDA | 138 | 116 | 112 | 124 | 118 −14% | 111 −4% | 97 −13% |
| Net profit | 105 | 87 | 77 | 97 | 88 −16% | 81 −7% | 68 −12% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
